Unknown NA INTERVENTIONAL 2-arm NCT02988011

Improving Glucose and Lipid Metabolism Through Caloric Restriction Using Diet or Surgery (CRUDOS) (CRUDOS)

Influence of Weight Loss by Diet and Surgery on Metabolomic Profile, Body Composition, and Tissue Specific Glucose Uptake: Insights in Type 2 Diabetes Regression (CRUDOS Study)

Sponsor: AstraZeneca

Conditions Bariatric Surgery Candidate Insulin Sensitivity Metabolism Disorder, Glucose Metabolism and Nutrition Disorder Type2 Diabetes Weight Loss

Interventions Gastric by-pass surgery Low-caloric diet

Updated 6 times since 2017 Last updated: Oct 25, 2017 Started: Feb 28, 2016 Primary completion: Jun 30, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02988011, this NA trial focuses on Bariatric Surgery Candidate and Insulin Sensitivity and remains ongoing. Sponsored by AstraZeneca, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Jan 2021 [monthly]

Recruiting NA
Nov 2017 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jan 2017 — Nov 2017 [monthly]

Not Yet Recruiting NA

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Uppsala University

Data source: Uppsala University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Uppsala, Sweden